Encompass Health Corporation $EHC is Copeland Capital Management LLC’s 6th Largest Position

Copeland Capital Management LLC boosted its stake in shares of Encompass Health Corporation (NYSE:EHC) by 16.8% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 892,823 shares of the company’s stock after purchasing an additional 128,120 shares during the quarter. Encompass Health accounts for 1.9% of Copeland Capital Management LLC’s investment portfolio, making the stock its 6th largest position. Copeland Capital Management LLC’s holdings in Encompass Health were worth $86,363,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently made changes to their positions in EHC. Royal Bank of Canada grew its position in Encompass Health by 21.5% in the first quarter. Royal Bank of Canada now owns 88,470 shares of the company’s stock worth $8,960,000 after acquiring an additional 15,677 shares during the period. Millennium Management LLC raised its position in Encompass Health by 38.4% in the first quarter. Millennium Management LLC now owns 92,197 shares of the company’s stock valued at $9,338,000 after purchasing an additional 25,574 shares during the period. Caxton Associates LLP acquired a new position in shares of Encompass Health in the 1st quarter valued at $259,000. Walleye Capital LLC grew its holdings in shares of Encompass Health by 667.6% during the 2nd quarter. Walleye Capital LLC now owns 6,522 shares of the company’s stock worth $800,000 after purchasing an additional 7,671 shares during the period. Finally, Gamco Investors INC. ET AL purchased a new position in shares of Encompass Health during the 2nd quarter worth $588,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Insider Activity

In other news, EVP Patrick William Tuer sold 682 shares of the stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $104.56, for a total value of $71,309.92. Following the transaction, the executive vice president owned 24,755 shares in the company, valued at approximately $2,588,382.80. This represents a 2.68% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 1.80% of the company’s stock.

Encompass Health Stock Down 0.2%

EHC stock opened at $112.24 on Friday. The company’s 50 day moving average price is $104.47 and its 200 day moving average price is $103.62. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.17 and a current ratio of 1.17. Encompass Health Corporation has a fifty-two week low of $92.77 and a fifty-two week high of $127.99. The firm has a market capitalization of $11.13 billion, a price-to-earnings ratio of 18.74, a PEG ratio of 2.45 and a beta of 0.74.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Thursday, April 30th. The company reported $1.60 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.51 by $0.09. Encompass Health had a net margin of 10.04% and a return on equity of 18.28%. The company had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.57 billion. During the same quarter in the previous year, the firm earned $1.37 earnings per share. The firm’s quarterly revenue was up 9.0% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. On average, equities research analysts anticipate that Encompass Health Corporation will post 5.97 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st were issued a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend was Wednesday, July 1st. Encompass Health’s payout ratio is 12.69%.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on EHC. Barclays reduced their price objective on shares of Encompass Health from $153.00 to $140.00 and set an “overweight” rating on the stock in a report on Tuesday, May 5th. Weiss Ratings downgraded shares of Encompass Health from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, June 26th. Leerink Partners set a $152.00 price objective on shares of Encompass Health in a research report on Friday, May 22nd. TD Cowen started coverage on Encompass Health in a research report on Thursday, May 28th. They issued a “buy” rating and a $125.00 target price on the stock. Finally, Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $143.86.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.